FDA.reportPublic FDA data

bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal]

RxCUI
1049299
RxNorm name
bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal]
Term type
SBD
Status
Active
Updated
2026-11-01 02:59:40

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
012011
Active start
012011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bismuth subsalicylate17.5 MG / 1 MLbismuth subsalicylatebismuth subsalicylate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Suspension316969

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bismuth subsalicylate19478

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
RXNAV_STRBismusal 1.75 % Oral Suspension1NAMES
RxNorm Namebismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal]1NAMES
RxNorm Synonym
2 linked values
2NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID978286be-3707-48c3-a1ee-fa6517bfdf501CODES
RxCUI10492991CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 3 matching rows.

NDC11, Source, Active table
NDC11SourceActive
46066024407rxnav_ndcsyes
30798033435rxnav_historical
58005070007rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
978286be-3707-48c3-a1ee-fa6517bfdf50Bismusal 1.75 % Oral Suspension [PSN] · bismuth subsalicylate 17.5 MG/ML Oral Suspension [Bismusal] [SBD] · Bismusal 1.75 % Oral Suspension [SY] · Bismusal 17.5 MG/ML Oral Suspension [SY]410BISMUSAL SUSPENSION20171011

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
285681f2-914d-41a9-a6fd-d4d9d53cde4cBISMUSAL SUSPENSION Anti-Diarrheal LiquidDurvet, Inc.20171101
978286be-3707-48c3-a1ee-fa6517bfdf50BISMUSAL SUSPENSIONAspen Veterinary Resources, Ltd.20171011
d685ed87-5059-4a68-8cfa-2cea2f7ed749BISMUSAL SUSPENSION Anti-Diarrheal LiquidSparhawk Laboratories, Inc.20171011

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
FDASPLD001729BismuthCHEMhas_chemical_structurebismuth subsalicylate
FDASPLN0000180183BismuthEPChas_epcbismuth subsalicylate
MEDRTD001729BismuthCHEMhas_ingredientbismuth subsalicylate
MEDRTD009942Organometallic CompoundsCHEMhas_ingredientbismuth subsalicylate
MEDRTD012459SalicylatesCHEMhas_ingredientbismuth subsalicylate
MEDRTD001778Blood Coagulation DisordersDISEASEci_withbismuth subsalicylate
MEDRTD002644ChickenpoxDISEASEci_withbismuth subsalicylate
MEDRTD003967DiarrheaDISEASEmay_treatbismuth subsalicylate
MEDRTD004342Drug HypersensitivityDISEASEci_withbismuth subsalicylate
MEDRTD004405Dysentery, BacillaryDISEASEmay_treatbismuth subsalicylate
MEDRTD004415DyspepsiaDISEASEmay_treatbismuth subsalicylate
MEDRTD004927Escherichia coli InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD006471Gastrointestinal HemorrhageDISEASEci_withbismuth subsalicylate
MEDRTD016481Helicobacter InfectionsDISEASEmay_treatbismuth subsalicylate
MEDRTD009325NauseaDISEASEmay_treatbismuth subsalicylate
MEDRTD011263Pregnancy Trimester, ThirdDISEASEci_withbismuth subsalicylate
MEDRTD013272Stomach DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTD014777Virus DiseasesDISEASEmay_treatbismuth subsalicylate
MEDRTN0000000226Acid-Base ActivityMOAhas_moabismuth subsalicylate
MEDRTN0000000160Cyclooxygenase InhibitorsMOAhas_moabismuth subsalicylate
MEDRTN0000009724Inhibition Gastric Acid SecretionPEhas_pebismuth subsalicylate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_VET_DRUGUS
ATTRIBUTESVET_DRUGUS
NAMESPrescribable SynonymBismusal 1.75 % Oral Suspension
SOURCESSourceMetathesaurus FDA Structured Product Labels